Insider · CIK 0001692359

Brudnick Richard

Reports to the SEC for 6 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001692359

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	SRRKScholar Rock Holding CorpA Award	Director	AAward	+6,839 sh	—	—	21,896
2026-06-04	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+4,310 sh	—	—	4,310
2025-05-29	SRRKScholar Rock Holding CorpS Sale	Director	SSale	−4,675 sh	$29.63	−$139K	16,457
2025-05-29	SRRKScholar Rock Holding CorpS Sale	Director	SSale	−1,400 sh	$30.00	−$42K	15,057
2025-05-22	SRRKScholar Rock Holding CorpA Award	Director	AAward	+7,632 sh	—	—	21,132
2025-05-22	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,206 sh	—	—	9,206
2025-05-20	PRMEPrime Medicine, Inc.P Purchase	Chief Business Officer	PPurchase	+20K sh	$1.19	+$23.8K	20,000
2025-02-27	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Business Officer	AAward	+225K sh	—	—	225,000
2024-12-05	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Business Officer	AAward	+19.3K sh	—	—	57,900
2024-06-27	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2024-06-27	SRRKScholar Rock Holding CorpA Award	Director	AAward	+13.5K sh	—	—	13,500
2024-05-17	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Business Officer	AAward	+19.3K sh	—	—	38,600
2024-02-21	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Business Officer	AAward	+136K sh	—	—	135,747
2023-04-06	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+56K sh	—	—	56,000
2023-03-31	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Business Officer	AAward	+136K sh	—	—	135,747
2023-01-12	VNRXVOLITIONRX LTDA Award	Director	AAward	+5,625 sh	—	—	27,936
2022-10-13	VNRXVOLITIONRX LTDA Award	Director	AAward	+2,625 sh	—	—	22,311
2022-06-23	VNRXVOLITIONRX LTDA Award	Director	AAward	+3,046 sh	—	—	19,686
2022-06-23	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director	AAward	+5,613 sh	—	—	8,635
2022-04-07	VNRXVOLITIONRX LTDA Award	Director	AAward	+1,640 sh	—	—	16,640
2022-04-07	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director	AAward	+3,022 sh	—	—	3,022
2022-02-16	Codiak BioSciences, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+16.3K sh	—	—	16,275
2022-02-16	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+10.9K sh	—	—	10,850
2022-01-19	Codiak BioSciences, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+8,400 sh	—	—	8,400
2022-01-19	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+41K sh	—	—	41,000
2021-03-25	VNRXVOLITIONRX LTDA Award	Director	AAward	+15K sh	—	—	15,000
2021-01-22	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+31K sh	—	—	31,000
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Business Development	DDisposition to Issuer	−31.8K sh	—	—	0
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Business Development	DDisposition to Issuer	−7,489 sh	—	—	0
2018-03-08	Bioverativ Inc.D Disposition to Issuer	EVP, Business Development	DDisposition to Issuer	−23K sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	EVP, Business Development	DDisposition to Issuer	−29.8K sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	EVP, Business Development	DDisposition to Issuer	−14.9K sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	EVP, Business Development	DDisposition to Issuer	−59.6K sh	—	—	0
2018-02-23	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−924 sh	$104.74	−$96.8K	22,952
2018-02-22	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−1,419 sh	$104.30	−$148K	23,876
2018-02-14	Bioverativ Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Business Development	MExercise/Conversion	−3,744 sh	—	—	7,489
2018-02-14	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−1,137 sh	$103.52	−$118K	25,295
2018-02-14	Bioverativ Inc.M Exercise/Conversion	EVP, Business Development	MExercise/Conversion	+3,744 sh	—	—	26,432
2018-01-31	Bioverativ Inc.Restricted Stock UnitsA Award	EVP, Business Development	AAward	+31.8K sh	—	—	31,818
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−339 sh	$49.56	−$16.8K	24,535
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−681 sh	$47.76	−$32.5K	23,854
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−66 sh	$43.42	−$2,865.72	23,788
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−1,100 sh	$43.42	−$47.8K	22,688
2017-02-28	Bioverativ Inc.A Award	EVP, Business Development	AAward	+27.4K sh	—	—	27,633
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−51 sh	$43.42	−$2,214.42	27,582
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−45 sh	$47.76	−$2,149.2	27,515
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−22 sh	$49.56	−$1,090.32	27,560
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−939 sh	$43.42	−$40.8K	26,576
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−411 sh	$49.56	−$20.4K	26,165
2017-02-28	Bioverativ Inc.F Tax Payment	EVP, Business Development	FTax Payment	−837 sh	$47.76	−$40K	25,328

Recent filings

Accepted (ET)
Jun 84
Brudnick Richard0001104659-26-071429
SEC(opens sec.gov)
May 304
Brudnick Richard0001415889-25-015003
SEC(opens sec.gov)
May 234
Brudnick Richard0001104659-25-052483
SEC(opens sec.gov)
May 224
Brudnick Richard0001894562-25-000030
SEC(opens sec.gov)
Mar 34
Brudnick Richard0001894562-25-000004
SEC(opens sec.gov)
Dec 94
Brudnick Richard0001894562-24-000048
SEC(opens sec.gov)
Jul 14
Brudnick Richard0001415889-24-018631
SEC(opens sec.gov)
May 214
Brudnick Richard0001894562-24-000023
SEC(opens sec.gov)
Feb 234
Brudnick Richard0001894562-24-000014
SEC(opens sec.gov)
Apr 104
Brudnick Richard0001415889-23-006405
SEC(opens sec.gov)
Apr 44
Brudnick Richard0001894562-23-000004
SEC(opens sec.gov)
Jan 134
Brudnick Richard0001477932-23-000275
SEC(opens sec.gov)
Oct 144
Brudnick Richard0001477932-22-007699
SEC(opens sec.gov)
Jun 244
Brudnick Richard0001477932-22-004666
SEC(opens sec.gov)
Apr 84
Brudnick Richard0001477932-22-002178
SEC(opens sec.gov)

Companies

Address

301 BINNEY STREET

CAMBRIDGE, MA, 02142